Early systemic failure after preoperative chemoradiotherapy for the treatment of patients with rectal cancer

Taesun Choi, Se-Jin Baek, Jung-Myun Kwak, Jin Kim, Seon Hahn Kim

Research output: Contribution to journalArticle

Abstract

Purpose: Distant metastasis can occur early after neoadjuvant chemoradiotherapy (CRT) in patients with rectal cancer. This study was conducted to evaluate the clinical characteristics of patients who developed early systemic failure. Methods: The patients who underwent neoadjuvant CRT for a rectal adenocarcinoma between June 2007 and July 2015 were included in this study. Patients who developed distant metastasis within 6 months after CRT were identified. We compared short- and long-term clinicopathologic outcomes of patients in the early failure (EF) group with those of patients in the control group. Results: Of 107 patients who underwent neoadjuvant CRT for rectal cancer, 7 developed early systemic failure. The lung was the most common metastatic site. In the EF group, preoperative carcinoembryonic antigen was higher (5 mg/mL vs. 2 mg/mL, P = 0.010), and capecitabine as a sensitizer of CRT was used more frequently (28.6% vs. 3%, P = 0.002). Of the 7 patients in the EF group, only 4 underwent a primary tumor resection (57.1%), in contrast to the 100% resection rate in the control group (P < 0.001). In terms of pathologic outcomes, ypN and TNM stages were more advanced in the EF group (P < 0.001 and P = 0.047, respectively), and numbers of positive and retrieved lymph nodes were much higher (P < 0.001 and P = 0.027, respectively). Conclusion: Although early distant metastasis after CRT for rectal cancer is very rare, patients who developed early metastasis showed a poor nodal response with a low primary tumor resection rate and poor oncologic outcomes.

Original languageEnglish
Pages (from-to)94-99
Number of pages6
JournalAnnals of Coloproctology
Volume35
Issue number2
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Chemoradiotherapy
Rectal Neoplasms
Neoplasm Metastasis
Therapeutics
Control Groups
Carcinoembryonic Antigen
Neoplasms
Adenocarcinoma
Lymph Nodes
Lung

Keywords

  • Chemoradiotherapy
  • Distant metastasis
  • Neoadjuvant therapy
  • Rectal neoplasms
  • Systemic failure

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Early systemic failure after preoperative chemoradiotherapy for the treatment of patients with rectal cancer. / Choi, Taesun; Baek, Se-Jin; Kwak, Jung-Myun; Kim, Jin; Kim, Seon Hahn.

In: Annals of Coloproctology, Vol. 35, No. 2, 01.01.2019, p. 94-99.

Research output: Contribution to journalArticle

@article{5301aab180604ea4a2e2234fa3e358f1,
title = "Early systemic failure after preoperative chemoradiotherapy for the treatment of patients with rectal cancer",
abstract = "Purpose: Distant metastasis can occur early after neoadjuvant chemoradiotherapy (CRT) in patients with rectal cancer. This study was conducted to evaluate the clinical characteristics of patients who developed early systemic failure. Methods: The patients who underwent neoadjuvant CRT for a rectal adenocarcinoma between June 2007 and July 2015 were included in this study. Patients who developed distant metastasis within 6 months after CRT were identified. We compared short- and long-term clinicopathologic outcomes of patients in the early failure (EF) group with those of patients in the control group. Results: Of 107 patients who underwent neoadjuvant CRT for rectal cancer, 7 developed early systemic failure. The lung was the most common metastatic site. In the EF group, preoperative carcinoembryonic antigen was higher (5 mg/mL vs. 2 mg/mL, P = 0.010), and capecitabine as a sensitizer of CRT was used more frequently (28.6{\%} vs. 3{\%}, P = 0.002). Of the 7 patients in the EF group, only 4 underwent a primary tumor resection (57.1{\%}), in contrast to the 100{\%} resection rate in the control group (P < 0.001). In terms of pathologic outcomes, ypN and TNM stages were more advanced in the EF group (P < 0.001 and P = 0.047, respectively), and numbers of positive and retrieved lymph nodes were much higher (P < 0.001 and P = 0.027, respectively). Conclusion: Although early distant metastasis after CRT for rectal cancer is very rare, patients who developed early metastasis showed a poor nodal response with a low primary tumor resection rate and poor oncologic outcomes.",
keywords = "Chemoradiotherapy, Distant metastasis, Neoadjuvant therapy, Rectal neoplasms, Systemic failure",
author = "Taesun Choi and Se-Jin Baek and Jung-Myun Kwak and Jin Kim and Kim, {Seon Hahn}",
year = "2019",
month = "1",
day = "1",
doi = "10.3393/ac.2018.10.01",
language = "English",
volume = "35",
pages = "94--99",
journal = "Annals of Coloproctology",
issn = "2287-9714",
publisher = "Korean Society of Coloproctology",
number = "2",

}

TY - JOUR

T1 - Early systemic failure after preoperative chemoradiotherapy for the treatment of patients with rectal cancer

AU - Choi, Taesun

AU - Baek, Se-Jin

AU - Kwak, Jung-Myun

AU - Kim, Jin

AU - Kim, Seon Hahn

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: Distant metastasis can occur early after neoadjuvant chemoradiotherapy (CRT) in patients with rectal cancer. This study was conducted to evaluate the clinical characteristics of patients who developed early systemic failure. Methods: The patients who underwent neoadjuvant CRT for a rectal adenocarcinoma between June 2007 and July 2015 were included in this study. Patients who developed distant metastasis within 6 months after CRT were identified. We compared short- and long-term clinicopathologic outcomes of patients in the early failure (EF) group with those of patients in the control group. Results: Of 107 patients who underwent neoadjuvant CRT for rectal cancer, 7 developed early systemic failure. The lung was the most common metastatic site. In the EF group, preoperative carcinoembryonic antigen was higher (5 mg/mL vs. 2 mg/mL, P = 0.010), and capecitabine as a sensitizer of CRT was used more frequently (28.6% vs. 3%, P = 0.002). Of the 7 patients in the EF group, only 4 underwent a primary tumor resection (57.1%), in contrast to the 100% resection rate in the control group (P < 0.001). In terms of pathologic outcomes, ypN and TNM stages were more advanced in the EF group (P < 0.001 and P = 0.047, respectively), and numbers of positive and retrieved lymph nodes were much higher (P < 0.001 and P = 0.027, respectively). Conclusion: Although early distant metastasis after CRT for rectal cancer is very rare, patients who developed early metastasis showed a poor nodal response with a low primary tumor resection rate and poor oncologic outcomes.

AB - Purpose: Distant metastasis can occur early after neoadjuvant chemoradiotherapy (CRT) in patients with rectal cancer. This study was conducted to evaluate the clinical characteristics of patients who developed early systemic failure. Methods: The patients who underwent neoadjuvant CRT for a rectal adenocarcinoma between June 2007 and July 2015 were included in this study. Patients who developed distant metastasis within 6 months after CRT were identified. We compared short- and long-term clinicopathologic outcomes of patients in the early failure (EF) group with those of patients in the control group. Results: Of 107 patients who underwent neoadjuvant CRT for rectal cancer, 7 developed early systemic failure. The lung was the most common metastatic site. In the EF group, preoperative carcinoembryonic antigen was higher (5 mg/mL vs. 2 mg/mL, P = 0.010), and capecitabine as a sensitizer of CRT was used more frequently (28.6% vs. 3%, P = 0.002). Of the 7 patients in the EF group, only 4 underwent a primary tumor resection (57.1%), in contrast to the 100% resection rate in the control group (P < 0.001). In terms of pathologic outcomes, ypN and TNM stages were more advanced in the EF group (P < 0.001 and P = 0.047, respectively), and numbers of positive and retrieved lymph nodes were much higher (P < 0.001 and P = 0.027, respectively). Conclusion: Although early distant metastasis after CRT for rectal cancer is very rare, patients who developed early metastasis showed a poor nodal response with a low primary tumor resection rate and poor oncologic outcomes.

KW - Chemoradiotherapy

KW - Distant metastasis

KW - Neoadjuvant therapy

KW - Rectal neoplasms

KW - Systemic failure

UR - http://www.scopus.com/inward/record.url?scp=85070228406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070228406&partnerID=8YFLogxK

U2 - 10.3393/ac.2018.10.01

DO - 10.3393/ac.2018.10.01

M3 - Article

AN - SCOPUS:85070228406

VL - 35

SP - 94

EP - 99

JO - Annals of Coloproctology

JF - Annals of Coloproctology

SN - 2287-9714

IS - 2

ER -